scispace - formally typeset
N

Ngoc B. Pham

Researcher at Griffith University

Publications -  36
Citations -  1258

Ngoc B. Pham is an academic researcher from Griffith University. The author has contributed to research in topics: Antibody & Medicine. The author has an hindex of 15, co-authored 32 publications receiving 1086 citations. Previous affiliations of Ngoc B. Pham include University of Florence.

Papers
More filters
Journal ArticleDOI

Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors

TL;DR: An unusual binding mode, with no interactions between the inhibitor molecule and the active site metal ion is previously unobserved for this enzyme class and presents a new opportunity for future drug design campaigns to target a mode of inhibition that differs substantially from classical inhibitors.
Journal ArticleDOI

Developing a drug-like natural product library.

TL;DR: A natural product library (NPL) is generated in which 85% of the isolated compounds had no Lipinski violations and demonstrates the feasibility of obtaining natural products known for rich chemical diversity with the required physicochemical properties for drug discovery.
Journal ArticleDOI

Direct Screening of Natural Product Extracts Using Mass Spectrometry

TL;DR: A proof-of-concept experiment to show direct affinity screening using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) is a rapid and informative approach for natural product extract screening is described.
Journal ArticleDOI

Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections

TL;DR: The diversity of marine natural products that have shown in- vivo efficacy or in-vitro potential against drug-resistant infections of fungal, viral, and parasitic origin are discussed, and their mechanism of action is described.
Journal ArticleDOI

Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry.

TL;DR: 96 low-molecular-weight natural products are identified as binding partners of 32 of the putative malarial targets and 79 fragments have direct growth inhibition on Plasmodium falciparum at concentrations that are promising for the development of fragment hits against these protein targets.